CoChat

Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus: Randomized Controlled Trial

Open access
Bjornstad, Petter, Schäfer, Michal, Truong, Uyen, Cree-Green, Melanie, Pyle, Laura, Baumgartner, Amy, Garcia Reyes, Yesenia, Maniatis, Aristides, Nayak, Sunil, Wadwa, R. Paul, Browne, Lorna P., Reusch, Jane E.B., Nadeau, Kristen J. · 2018 · Circulation
Cited by 143

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Background: Cardiovascular disease is the leading cause of mortality in type 1 diabetes mellitus (T1DM) and relates strongly to insulin resistance (IR). Lean and obese adolescents with T1DM have marked IR. Metformin improves surrogate markers of IR in T1DM, but its effect on directly measured IR and vascular health in youth with T1DM is unclear. We hypothesized that adolescents with T1DM have impaired vascular function and that metformin improves this IR and vascular dysfunction. Methods: Adolescents with T1DM and control participants underwent magnetic resonance imaging of the ascending (AA) and descending aorta to assess pulse wave velocity, relative area change, and maximal (WSS MAX ) and time-averaged (WSS TA ) wall shear stress. Participants with T1DM also underwent assessment of carotid intima-media thickness by ultrasound, brachial distensibility by DynaPulse, fat and lean mass by dual-energy x-ray absorptiometry, fasting laboratories after overnight glycemic control, and insulin sensitivity by hyperinsulinemic-euglycemic clamp (glucose infusion rate/insulin). Adolescents with T1DM were randomized 1:1 to 3 months of 2000 mg metformin or placebo daily, after which baseline measures were repeated. Results: Forty-eight adolescents with T1DM who were 12 to 21 years of age (40% body mass index [BMI] ≥90th percentile; 56% female) and 24 nondiabetic control participants of similar age, BMI, and sex distribution were enrolled. Adolescents with T1DM demonstrated impaired aortic health compared with control participants, including elevated AA and descending aorta pulse wave velocity, reduced AA and descending aorta relative area change, and elevated AA and descending aorta WSS MAX and WSS TA . Adolescents with T1DM in the metformin versus placebo group had improved glucose infusion rate/insulin (12.2±3.2 [mg·kg −1 ·min −1 ]/μIU/μL versus −2.4±3.6 [mg·kg −1 ·min −1 ]/μIU/μL, P =0.005; 18.6±4.8 [mg·lean kg −1 ·min −1 ]/μIU/μL versus −3.4±5.6 [mg·lean kg −1 ·min −1 ]/μIU/μL, P =0.005) and reduced weight (−0.5±0.5 kg versus 1.6±0.5 kg; P =0.004), BMI (−0.2±0.15 kg/m 2 versus 0.4±0.15 kg/m 2 ; P =0.005), and fat mass (−0.7±0.3 kg versus 0.6±0.4 kg; P =0.01). Glucose infusion rate/insulin also improved in normal-weight participants (11.8±4.4 [mg·kg −1 ·min −1 ]/μIU/μL versus −4.5±4.4 [mg·kg −1 ·min −1 ]/μIU/μL, P =0.02; 17.6±6.7 [mg·lean kg −1 ·min −1 ]/μIU/μL versus −7.0±6.7 [mg·lean kg −1 ·min −1 ]/μIU/μL, P =0.02). The metformin group had reduced AA WSS MAX (−0.3±0.4 dyne/cm 2 versus 1.5±0.5 dyne/cm 2 ; P =0.03), AA pulse wave velocity (−1.1±1.20 m/s versus 4.1±1.6 m/s; P =0.04), and far-wall diastolic carotid intima-media thickness (−0.04±0.01 mm versus −0.00±0.01 mm; P =0.049) versus placebo. Conclusions: Adolescents with T1DM demonstrate IR and impaired vascular health compared with control participants. Metformin improves IR, regardless of baseline BMI, and BMI, weight, fat mass, insulin dose, and aortic and carotid health in adolescents with T1DM. Metformin may hold promise as a cardioprotective intervention in T1DM. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT01808690.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.118.035525

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 143

Metadata

Authors
Bjornstad, P., Schäfer, M., Truong, U., Cree-Green, M., Pyle, L., Baumgartner, A., Garcia Reyes, Y., Maniatis, A., Nayak, S., Wadwa, R. P., Browne, L. P., Reusch, J. E. B., & Nadeau, K. J.
Venue
Circulation
Published
2018-12-18
Volume
138
Issue
25
Pages
2895-2907
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2907961170
Cited by
143
References
12
FWCI
11.43
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus: Randomized Controlled Trial. https://app.cochat.ai/papers/10.1161/circulationaha.118.035525
The paper
Bjornstad, P., Schäfer, M., Truong, U., Cree-Green, M., Pyle, L., Baumgartner, A., Garcia Reyes, Y., Maniatis, A., Nayak, S., Wadwa, R. P., Browne, L. P., Reusch, J. E. B., & Nadeau, K. J. (2018). Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus: Randomized Controlled Trial. Circulation. https://doi.org/10.1161/circulationaha.118.035525

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.